Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04441567 · ClinicalTrials.gov registry record · NA

Right-Size Clinic Visits Using Memora Platform for PROMIS

A NA study of Orthopedic Disorders, sponsored by Boston Medical Center.

Recruiting
Registry status
NA
Development phase
3,000
Enrollment target
1
Study location

NCT04441567: Recruiting NA study of Orthopedic Disorders, sponsored by Boston Medical Center.

NCT04441567 is a NA study of Orthopedic Disorders that is actively recruiting participants, run by Boston Medical Center. The registered enrollment target is 3,000 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (114% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04441567, a NA study of Orthopedic Disorders, is actively recruiting participants, sponsored by Boston Medical Center.

RECRUITING
Registry status
NA
Development phase
3,000 participants
Enrollment target
1
Study location

Study Summary

Developing novel methods of patient communication is crucial in providing value-based care to orthopedic patients. Healthcare technology platforms have been developed to improve patient communication methods particularly for the administration of patient-reported outcome measures (PROMs). However, the majority of these interventions rely on web-based platforms that require patients to have computer access. Among American households earning less than $30,000 per year, only 59% have access to a desktop or laptop and just 47% have broadband internet at home compared to mobile phone penetration which is estimated at 95% of which 93% regularly use text messages. The use of phone messaging may be the most effective means to have patients complete PROMs. The Patient-Reported Outcomes Measurement Information System (PROMIS) is an NIH-funded, clinically validated method of tracking patient-reported outcomes to efficiently assess patient health status. PROMIS utilizes Item Response Theory (IRT) and computerized adaptive testing (CAT) to improve measurement precision and decrease survey time as compared to traditional PROMs. The purpose of this two-phase study is to utilize Memora Health's text-messaging platform to collect web-based PROMIS CAT surveys from patients (Phase 1) and use this information to right-size clinic visits (Phase 2).

Primary Outcome

Right-size clinic visits for patients recovering at/better than expected while maintaining or improving overall patient-reported outcomes (PROMS) will be assessed by comparing to the mean condition-specific recovery curve from phase 1. Earlier clinic visits will be scheduled for those who are more than 1 standard deviation from the mean recovery at any time point and less frequent visits for all others to establish the right size clinic visits.

Conditions Studied

Interventions

  • OTHER Right-size clinic visits

Study Locations (1)

Massachusetts

  • Boston Medical Center - Boston

Trial Details

FieldValue
Enrollment Target 3,000 participants
Start Date 2021-05-10
Est. Completion 2026-09
Phase NA
Boston Medical Center

253 total trials

What NCT04441567 shows while recruiting

NCT04441567 is an interventional study that assigns participants to a tested intervention. Its 3,000 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (114% higher).

The record links to 1 condition, with Orthopedic Disorders appearing as the primary indexed condition, and to 1 intervention - of which Right-size clinic visits is the first listed.

NCT04441567 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT04441567 about?

NCT04441567 is a clinical study titled "Right-Size Clinic Visits Using Memora Platform for PROMIS". Developing novel methods of patient communication is crucial in providing value-based care to orthopedic patients. Healthcare technology platforms have been developed to improve patient communication methods particularly for the administration of patient-reported outcome measures (PROMs). However, t...

What is the current status of trial NCT04441567?

This trial is currently recruiting. It is a NA study. The enrollment target is 3,000 participants. The study started on 2021-05-10. Estimated completion is 2026-09.

What conditions does trial NCT04441567 study?

This clinical trial studies the following conditions: Orthopedic Disorders.

What interventions are being tested in trial NCT04441567?

The interventions under investigation include: Right-size clinic visits (OTHER).

Who is sponsoring clinical trial NCT04441567?

This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04441567 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

How this trial's enrollment target compares

Where NCT04441567's enrollment target sits among peer trials

3,000 40th of 2000 higher than 1,959 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00004847 · 3,000 participants · Phase 1

    Diagnosis of Pheochromocytoma

  • NCT00478712 · 3,000 participants

    Hirschsprung Disease Genetic Study

  • NCT00579566 · 3,000 participants

    Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma

  • NCT00816114 · 3,000 participants

    Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04441567, the US trial registry maintained by the National Library of Medicine. NCT04441567 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.